• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床样本中与依曲韦林表型敏感性降低相关的额外HIV-1突变模式。

Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples.

作者信息

Kagan Ron M, Sista Prakash, Pattery Theresa, Bacheler Lee, Schwab Dale A

机构信息

Department of Infectious Diseases, Quest Diagnostics Nichols Institute, San Juan Capistrano, California 92675, USA.

出版信息

AIDS. 2009 Jul 31;23(12):1602-5. doi: 10.1097/QAD.0b013e32832d8771.

DOI:10.1097/QAD.0b013e32832d8771
PMID:19474648
Abstract

We investigated the phenotypic impact of a number of uncommon amino acid substitutions at HIV-1 reverse transcriptase positions 103 and 138, which are not part of the etravirine resistance score and were found in combination with the high-impact mutation K101P. Etravirine phenotypic fold changes were 380-1400 for K101P + E138A/G/Q + K103N/S/T + V179I and 12-130 for K101P + (K103S +/- V179I) in the absence of E138A/G/Q. Although the effect of K103S is unclear, additional position 138 substitutions seem important for etravirine susceptibility.

摘要

我们研究了HIV-1逆转录酶第103位和138位一些不常见氨基酸替代的表型影响,这些位置不属于依曲韦林耐药评分的一部分,且发现它们与高影响突变K101P同时出现。对于K101P + E138A/G/Q + K103N/S/T + V179I,依曲韦林表型倍数变化为380 - 1400;对于K101P + (K103S +/- V179I)且不存在E138A/G/Q时,表型倍数变化为12 - 130。虽然K103S的影响尚不清楚,但138位的其他替代似乎对依曲韦林敏感性很重要。

相似文献

1
Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples.临床样本中与依曲韦林表型敏感性降低相关的额外HIV-1突变模式。
AIDS. 2009 Jul 31;23(12):1602-5. doi: 10.1097/QAD.0b013e32832d8771.
2
Effect of mutations at position E138 in HIV-1 reverse transcriptase on phenotypic susceptibility and virologic response to etravirine.HIV-1 逆转录酶位置 E138 突变对依曲韦林表型敏感性和病毒学应答的影响。
J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):18-22. doi: 10.1097/QAI.0b013e3182237f74.
3
Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.简短通讯:在美国接受常规1型HIV耐药性检测的样本中,依曲韦林敏感性的基因型和表型流行情况
AIDS Res Hum Retroviruses. 2011 Dec;27(12):1271-5. doi: 10.1089/AID.2011.0049. Epub 2011 Jun 11.
4
Prevalence in the USA of rilpivirine resistance-associated mutations in clinical samples and effects on phenotypic susceptibility to rilpivirine and etravirine.美国临床样本中与rilpivirine耐药相关突变的流行情况及其对rilpivirine和etravirine表型敏感性的影响。
Antivir Ther. 2014;19(8):819-23. doi: 10.3851/IMP2771. Epub 2014 Apr 4.
5
Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies.依曲韦林耐药性分析:来自随机、对照 III 期临床研究的基线基因型和表型数据的综合分析。
AIDS. 2010 Feb 20;24(4):503-14. doi: 10.1097/QAD.0b013e32833677ac.
6
Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms.临床实践中依曲韦林病毒学反应的预测:三种基因型算法的比较
J Med Virol. 2009 Apr;81(4):672-7. doi: 10.1002/jmv.21461.
7
Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.HIV-1 逆转录酶位置 E138 突变及其与 M184I 突变的相互作用对定义非核苷类逆转录酶抑制剂利匹韦林和依曲韦林耐药模式的影响。
Antimicrob Agents Chemother. 2013 Jul;57(7):3100-9. doi: 10.1128/AAC.00348-13. Epub 2013 Apr 22.
8
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens.HIV-1 逆转录酶连接域突变不会影响依曲韦林的敏感性和依曲韦林含药方案的病毒学应答。
Antimicrob Agents Chemother. 2011 Jun;55(6):2872-9. doi: 10.1128/AAC.01695-10. Epub 2011 Apr 4.
9
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.耐药突变对既往非核苷类类似物治疗失败的HIV患者依曲韦林敏感性的表型影响。
AIDS. 2008 Nov 12;22(17):2395-8. doi: 10.1097/QAD.0b013e32831692fb.
10
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.对奈韦拉平和依非韦伦耐药的临床样本中依曲韦林相关突变的发生率。
J Antimicrob Chemother. 2008 Nov;62(5):909-13. doi: 10.1093/jac/dkn297. Epub 2008 Jul 23.

引用本文的文献

1
HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries.喀麦隆接受抗逆转录病毒治疗失败的个体中HIV-1对第二代非核苷类逆转录酶抑制剂的交叉耐药性:对低收入和中等收入国家长效治疗方案使用的影响
JAC Antimicrob Resist. 2025 Apr 28;7(2):dlaf059. doi: 10.1093/jacamr/dlaf059. eCollection 2025 Apr.
2
Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy.成功分离出两名停药患者具有感染性和高滴度的人源单核细胞衍生的 HIV-1。
PLoS One. 2013 May 31;8(5):e65071. doi: 10.1371/journal.pone.0065071. Print 2013.
3
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.N348I 突变对非 B 型 HIV-1 中 HIV-1 逆转录酶的非核苷类逆转录酶抑制剂耐药性的影响。
Antimicrob Agents Chemother. 2011 Apr;55(4):1806-9. doi: 10.1128/AAC.01197-10. Epub 2011 Jan 31.
4
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes.抗艾滋病毒初治患者中感染非 B 型 HIV-1 亚型对依曲韦林(TMC-125)的耐药相关突变。
Antimicrob Agents Chemother. 2010 Feb;54(2):728-33. doi: 10.1128/AAC.01335-09. Epub 2009 Dec 14.